PROSPECTIVE EVALUATION OF PROGNOSTIC VALUE OF MORPHOMETRY IN PATIENTS WITH PRIMARY BREAST-CANCER

被引：58

作者：

VANDERLINDEN, JC

BAAK, JPA

LINDEMAN, J

HERMANS, J

MEYER, CJLM

机构：

[1] FREE UNIV HOSP,INST PATHOL,DE BOELELAAN 1117,1007 MB AMSTERDAM,NETHERLANDS

[2] STATE UNIV LEIDEN,DEPT MED STAT,2312 AV LEIDEN,NETHERLANDS

[3] STICHTING SAMENWERKING DELFTSE ZIEKENHUIZEN,DELFT,NETHERLANDS

来源：

JOURNAL OF CLINICAL PATHOLOGY | 1987年 / 40卷 / 03期

关键词：

D O I：

10.1136/jcp.40.3.302

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：302 / 306

页数：5

共 35 条

[1] ESTROGEN AND PROGESTERONE RECEPTORS AND DISEASE-FREE INTERVAL IN PRIMARY BREAST-CANCER [J].

ALANKO, A ;

HEINONEN, E ;

SCHEININ, TM ;

TOLPPANEN, EM ;

VIHKO, R .

BRITISH JOURNAL OF CANCER, 1984, 50 (05) :667-672

[2]

[Anonymous], 1982, MORPHOMETRY

[3]

AZZOPARDI J G, 1982, American Journal of Clinical Pathology, V78, P806

[4]

Baak J. P. A., 1983, MANUAL MORPHOMETRY D

[5] PROGNOSTIC INDICATORS IN BREAST-CANCER - MORPHOMETRIC METHODS [J].

BAAK, JPA ;

KURVER, PHJ ;

DESNOONIEWLAAT, AJE ;

DEGRAEF, S ;

MAKKINK, B ;

BOON, ME .

HISTOPATHOLOGY, 1982, 6 (03) :327-339

[6]

BAAK JPA, 1985, CANCER, V56, P374, DOI 10.1002/1097-0142(19850715)56:2<374::AID-CNCR2820560229>3.0.CO

[7]

2-9

[8]

BAAK JPA, 1983, PATH RES PRACT, V187, P307

[9] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

[10]

DIXON WJ, 1983, BMDP STATISTICAL SOF

← 1 2 3 4 →